PARTNER NEWS:Wed, May 8, 10:19 AM, Zacks
Ligand (LGND) Beats Q1 Earnings, Misses Sales Estimates
Ligand Pharmaceuticals (LGND) reports mixed first-quarter results. Management reiterates the 2024 financial outlook.
Wed, May 1, 8:01 AM, Zacks
Analysts Estimate Arcturus Therapeutics (ARCT) to Report a Decline in Earnings: What to Look Out for
Arcturus Therapeutics (ARCT) doesn t possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.